GT Biopharma selected for oral presentation at SITC annual meeting
GTBP•GT Biopharma will give an oral presentation at the SITC 2026 Annual Meeting in Phoenix, scheduled for Nov. 4-8. The presentation on KRAS inhibition sensitizing pancreatic cancer to NK cell immunotherapy is scheduled for Nov. 6, from 3:05 to 3:20 p.m. MT.
1. Presentation schedule
GT Biopharma will give an oral presentation at the SITC 2026 Annual Meeting, scheduled for Nov. 4-8 in Phoenix. Paarth Dodhiawala of the University of Minnesota Medical School will present on KRAS inhibition sensitizing pancreatic cancer to NK cell immunotherapy on Nov. 6, from 3:05 to 3:20 p.m. MT.
